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Abstracts 
 
i. Zusammenfassung 
 
Die Entfernung der inneren Grenzmembran (internal limiting membrane, ILM) der 
Netzhaut während der Vitrektomie hat sich weitgehend als effektive Theapieoption in der 
Makulaforamenchirurgie für bestmögliche funktionelle und anatomische Ergebnisse 
durchgesetzt. Der ILM kommt bei der Untersuchung der vitreoretinalen Grenzfläche eine 
zentrale Bedeutung zu, da sie chirurgisch gewonnen und untersucht werden kann, wie 
vitreale und epiretinale Traktionen auf die Netzhaut übertragen werden. Im Gegensatz zu 
den morphologischen Veränderungen der vitrealen Seite der ILM, sind die Kenntnisse über 
morphologische Veränderungen der retinalen Seite der ILM auf wenige Untersuchungen 
beschränkt.  
Ziel dieser Untersuchung war, das Vorkommen retinaler Zellen und Zellreste an der 
inneren Grenzmembran bei 109 Patienten zu untersuchen. 
Es wurde bei 79 Augen mit Makulaforamina (MF) und bei 30 Augen mit anderen 
traktiven Makulopathien eine Vitrektomie durchgeführt. Die patienten wurden in zwei 
Gruppen eingeteilt: eine Gruppe ohne Anwendung intravitrealer Farbstoffe und eine zweite 
Gruppe mit Anwendung intravitrealer Farbstoffe. Die Gruppe ohne Anwendung intravitrealer 
Farbstoffe bestand aus 32 idiopathischen MF, 13 rezidivierenden MF, 8 sekundären MF, 11 
Makular Pucker, 1 Augen mit Diabetischer Retinopathie, 3 Augen mit Proliferativer 
Vitreoretinopathie, und 6 Augen mit Vitreomakulärem Traktionssyndrom. Die Gruppe mit 
Anwendung intravitrealer Farbstoffe bestand aus 17 idiopathischen MF, 6 rezidivierenden MF, 
3 sekundären MF, 6 Makular Pucker und 3 Augen mit Diabetischer Retinopathie. 
Alle Präparate wurden nach der Entfernung bei der Operation sofort in 4% 
Glutaraldehyd fixiert und mit Osmiumtetroxid nachfixiert. Die Präparate wurden für die 
konventionelle Licht- und Elektronenmikroskopie in Serienschnitten aufbereitet. 1379 
Semidünnschnitte und über 400 Ultradünnschnitte wurden ausgewertet.  
Im lichtmikroskopischen Bild zeigte sich die ILM als dünnes blaues Band in allen 
Präparaten. Von den 109 Patienten fanden sich bei 41 Patienten vitreale Zellen oder Zellreste 
in der Gruppe ohne Anwendung intravitrealer Farbstoffe und bei 20 Patienten in der Gruppe 
mit Anwendung intravitrealer Farbstoffe. Retinale Zellen oder Zellreste fanden sich bei 16 
Patienten in der Gruppe ohne Anwendung intravitrealer Farbstoffe und bei 9 Patienten in der 
Gruppe mit Anwendung intravitrealer Farbstoffe.  
Beim Vergleich idiopathischer Makulaforamina und Macular pucker mit und ohne 
Farbstoff wurden signifikant wenige retinale Zellreste gefunden in der Gruppe ohne 
Anwendung intravitrealer Farbstoffe. Verglichen mit anderen Makulopathien wurden 
signifikant weniger Zellreste bei Makulaforamina gefunden in der Gruppe ohne Anwendung 
intravitrealer Farbstoffe. 15,1% aller Makulaforamina und 38,1% der anderen Makulopathien 
hatten Zellreste an der retinalen Seite der ILM. Es zeigte sich kein Unterschied in 
Abhängigkeit von Alter, Auge oder Operateur. 
Bei den 25 Patienten, bei denen lichtmikroskopisch retinale Zellreste gefunden wurden, 
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wurde eine elektronenmikroskopische Untersuchung durchgeführt, um die gleiche Stelle zu 
treffen, an der Zellreste im lichtmikroskopischen Bild gefunden wurden. Die retinalen 
Zellreste wurden anhand des elektronenmikroskopischen Bildes der Grösse und der Form 
nach in vier Grade eingeteilt. Grad 1 entspricht kleinen runden Zellfragmenten, deren 
Durchmesser weniger als 1 µm war. Grad 2 entspricht mittleren runden Zellfragmenten, 
deren Durchmesser zwischen 1 und 2 µm war. Grad 3 entspricht großen irregulären 
Zellfragmenten, deren Durchmesser größer als 2 µm war. Grad 4 entspricht vollständigen 
Zellen mit Zellorganellen wie Zellkern, Mitochondrien, Golgi-Komplex und 
Endoplasmatischem Retikulum. Von den 8 Makulaforamen-Patienten mit retinalen 
Zellfragmenten in der Gruppe ohne Anwendung intravitrealer Farbstoffe zeigte kein Patient 
ganze Zellen (Grad 4), während bei den anderen Traktionsmakulopathien in der Gruppe ohne 
Anwendung intravitrealer Farbstoffe 63% der Präparate ganze Zellen an der retinalen Seite 
der ILM zeigten. Diese Unterschied könnte durch die stärkere Traktion und Fältelung der ILM 
bei diesen Erkrankungen mit bedingt sein. 
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ii. Summary 
 
Removal of the internal limiting membrane (ILM) during vitrectomy is widely accepted 
as an effective therapy for macular holes and other traction maculopathies. The ILM plays an 
important role in these diseases, because it can transmit vitreal and epiretinal traction to the 
retina. Compared to the morphological changes on the vitreal side of the ILM, the 
understanding of the retinal side is limited. 
The purpose of this study was to investigate the cells and cell fragments on the retinal 
side of the ILM in 109 patients. 
Vitrectomy was performed in 79 eyes with macular holes and 30 eyes with other 
traction maculopathies. The patients were divided into two groups: without vital dye and 
with vital dye administration. We included 32 eyes with idiopathic macular holes, 13 eyes 
with recurrent macular holes, 8 eyes with secondary macular holes, 11 eyes with macular 
pucker, one eye with diffuse macular edema in proliferative diabetic retinopathy, 3 eyes with 
proliferative vitreoretinopathy and 6 eyes with vitreomacular traction syndrome in the group 
without dye administration. In the dye administration group, we included 17 eyes with 
idiopathic macular holes, 6 eyes with recurrent macular holes, 3 eyes with secondary 
macular holes, 6 eyes with macular pucker and 3 eyes with proliferative diabetic retinopathy. 
All specimens were immediately placed in 4% glutaraldehyde for fixation after removal 
during surgery. Osmium tetroxide was used for postfixation. The specimens were prepared 
for conventional light and electron microscopy in serial sections. 1379 light- and more than 
400 electronmicroscopic sections were evaluated. 
In light microscopy, the ILM showed a thin strand in all specimens. Cells and cell 
fragments were found in 41 specimens in the group without dye administration and in 20 
specimens in the group of dye administration on the vitreal side of the ILM. On the retinal 
side of the ILM, cell fragments were found in 16 specimens at the ILM by light microscopy in 
the group without dye administration and in 9 specimens in the dye administration group. 
A significant difference was seen between the presence of retinal debris between the 
group without dye administration and the dye administration group, when comparing 
idiopathic macular hole and macular pucker eyes only. Significant fewer cells or cell 
fragments were observed in macular holes in the group without dye administration, 
compared with other traction maculopathies. About 15.1% of specimens with macular holes 
and 38.1% with other traction maculopathies showed cell fragments on the retinal side of 
the ILM. No difference was shown depending on age, eye, or surgeon. 
Twenty-five specimens in whom retinal cell fragments were found were evaluated by 
electron microscopy. Four distinct morphologic patterns were observed on the retinal side of 
the ILM depending on the size and shape of cellular fragments. Grade 1 were small round 
cell fragments <1 µm in diameter. Grade 2 were medium sized (1-2 µm in diameter) cell 
fragments. Grade 3 were large cell fragments of more than 2 µm in diameter. Grade 4 were 
entire retinal cell bodies with cellular organelles such as nucleus, mitochondriae, golgi 
complexes, and endoplasmatic reticulum. In the group without dye administration, complete 
retinal cell bodies were not seen in eyes with macular holes, but in 63% of eyes with other 
traction maculopathies. The difference could be caused by more severe traction and 
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puckering of the ILM in other traction maculopathies compared with macular hole eyes. 
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1  INTRODUCTION  
 
Peeling of the internal limiting membrane (ILM) during macular surgery is a procedure 
widely accepted in macular traction disorders. The rationale for peeling the ILM is to relieve 
vitreoretinal traction. Tangential or antero-posterior traction to the retina exerted by the 
vitreous or epiretinal membranes (ERM) may promote glial cell migration and proliferation. 
Numerous studies show that removal of the ILM during macular surgery has a favorable 
functional and anatomical outcome and minimizes the recurrence of ERM. (Park, Sipperley et 
al. 1999; Brooks 2000; Gandorfer, Messmer et al. 2000; Mester and Kuhn 2000; Smiddy, 
Feuer et al. 2001; Scott, Moraczewski et al. 2003; Al-Abdulla, Thompson et al. 2004; Kwok, 
Lai et al. 2005; Haritoglou, Schumann et al. 2006; Patel, Hykin et al. 2006) However, there are 
some reports demonstrating functional deficits mostly after dye-assisted ILM removal. 
(Haritoglou, Gass et al. 2001; Gass, Haritoglou et al. 2003; Haritoglou, Gandorfer et al. 2003) 
This made researchers paying more attention to a potential retinal injury caused by the 
ILM-peeling itself or by the vital dye used for better visualization of the translucent ILM.  
The ILM is the basal lamina of Müller cells. Their footplates are directly adjacent to the 
ILM. Any injury of these footplates or of Müller cell bodies may affect retinal neurons 
because Müller cells hold a number of functions in the retinal cell structure. (Newman and 
Reichenbach 1996) They are thought to be important for neuronal waste exchange. Müller 
cells supply endproducts of anaerobic metabolism for neurons and synthesize retinoic acid 
from retinol. They are involved in phagocytosis of neuronal debris and release neuroactive 
substances. Thus, removal of the ILM with potential damage to Müller cells may influence 
functional outcome.  
The retinal injury may leave cells or cell fragments on the retinal side of the ILM. After 
indocyanine green (ICG)-assisted ILM removal, ultrastructural and histopathologic studies 
reported on the presence of retinal cell fragments at the ILM derived from Müller cells. 
(Gandorfer, Haritoglou et al. 2001; Haritoglou, Gandorfer et al. 2002) In previous studies on 
ILM removal without intravitreal dye administration, these retinal cell fragments appeared 
rather small or were not found at all. (Schumann, Schaumberger et al. 2006; Schumann, 
Gandorfer et al. 2009) However, an investigation of a large series of ILM specimens removed 
without staining is still pending. Therefore, we focused on the retinal side of the ILM and 
evaluated 109 surgical ILM specimens obtained during macular surgery with and without 
intravitreal dye administration. 
 
 
1.1  Normal Anatomy 
 
The vitreoretinal interface is defined as the structure situated between the outer 
vitreous cortex and the plasma membrane of the Müller cell. It is the site of five potentially 
blinding vitreoretinal disorders: macular hole, macular pucker, diabetic vitreoretinopathy, 
proliferative vitreoretinopathy and vitreomacular traction syndrome. (Sebag and Hageman 
2000)  
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1.1.1  The vitreoretinal interface 
 
The vitreoretinal interface consists of three components, which are: anchoring fibrils of 
the vitreous body, the internal limiting membrane and the cell membrane of Müller cells 
adjacent to the retinal side of the ILM. 
There are attachments to the internal limiting membrane from both the retina and the 
vitreous. On the retinal side, the terminal extensions of the Müller cells form an uneven but 
continuous border. By varying its thickness, the ILM fills in areas of relative excavation in the 
uneven surface of the Müller cell endfeet, producing a smooth inner surface of the retina. 
 
 
1.1.1.1  Outer vitreous cortex fibrils 
 
The vitrous is composed of 97%-99% water and the remaining tissue includes mainly 
collagen fibrils, glycosaminoglycan, hyaluronan and chondroitin sulfate. (Scott 1992) The 
collagen fibrils are thought to be charged of the connection between the vitreous gel and the 
internal limiting membrane. There are no direct connections between the posterior vitreous 
cortex and the retina. Only at the retinal periphery fibers of the vitreous body can be seen 
passing into the internal limiting membrane. The exact nature of the adhesion between the 
posterior vitreous cortex and the ILM is not known, but most probably results from the 
action of the various extracellular matrix molecules found at this interface, including 
fibronectin and laminin. (Sebag 1991; Sebag 1992)  
 
 
1.1.1.2  Internal limiting membrane 
 
Three horizontal membranes have been identified within the retina, but only one of 
these, the internal limiting membrane, has the characteristic structure of a basement 
membrane. Although the middle limiting membrane and the external limiting membrane has 
both the light microscopic appearance of membranes and a potential metabolic barrier 
function, neither of them is a true basement membrane. The middle limiting membrane is a 
pseudomembrane formed by the photoreceptor and bipolar cell synapse, which are 
juxtaposed in the inner zone of the outer plexiform layer. The external limiting membrane is 
formed by the continuous line of intermediate junctions between adjacent photoreceptor 
cells and the Müller cells. 
The inner limiting membrane is seen as delicate collagen-like fibrils in a dense matrix. It 
is separated from the Müller cells by an electron-lucent zone which is  traversed by fibrils. 
(Foos 1972) At the posterior pole, the membrane is 10-20 µm thick and shows an irregular 
outer surface which follows the contours of the Müller cells. It has a flat inner surface, with 
delicate collagen-like fibrils of the vitrous cortex. (Fine and Tousimis 1961) 
Ultrastructural work has shown that it consists of a true basement membrane, with 
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intimate association with the collagen fibrils of the vitreous body and with the cell 
membrane of Müller cells. 
In electron microscopy, the internal limiting membrane is composed of three structures 
as other basement membranes: lamina fibroreticularis, lamina densa and lamina lucida. 
Ultrastructural studies have shown that the inner portion of the internal limiting membrane, 
the lamina fibroreticularis, is formed by vitreous fibrils; the middle portion, lamina densa, is 
formed by collagen, and the outer portion, lamina lucida, consists mostly of the basement 
membrane of Müller cells. (Foos 1972)  
The internal limiting membrane is also termed basal lamina of the retina, internal 
limiting lamina or Membrana limitans interna retinae in the literatures. It has been studied 
since 1871. (Heegaard 1997) 
A regional difference in thickness of the ILM was found in human adult eyes. The ILM is 
thickest in the macular region. The length of vitreous fibrils close to the ILM also varied 
between the four regions in human eyes. The longest fibrils are in the ora serrata region, the 
second longest in the equatorial region, the next longest in the optic disc region and the 
shortest in the macular region. (Heegaard 1997) 
 
 
1.1.1.3  The processes of Müller cells 
 
Müller cells are the largest cells in the retina and the predominant macroglial cell of the 
retina. These cells span the entire thickness of the retina and maintain the structure of the 
retina and are the only cell type that occupies the full thickness of the retina from the 
external to the internal limiting membrane. Their cytoplasmic extensions reach between and 
envelop neuronal cell bodies and processes, filling all intercellular spaces except for synapses 
between the neural cells, spaces in the adventitia of large blood vessels, and the small (less 
than 20 nm) potential spaces between ganglion cell axons and dendrites. This vast extension 
of Müller cell processes effectively enmeshes the remainder of the retina so that all cell 
bodies and cellular processes between the external and internal limiting membranes reside 
in tunnels formed by Müller cells.  
The mature Müller cell has four types of cell processes. Radial processes arise from both 
sides of the cell body in the internal nuclear layer and extend through the retinal processes 
to form part of the internal limiting membrane. Fine horizontal processes extend laterally in 
the two plexiform layers and through the nerve fiber layer.  
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1.1.2  Morphological characteristics of cells implicated in the 
pathogenesis of traction maculopathien 
 
1.1.2.1  Müller cell  
 
In theory, disease of the Müller cells could reflect itself in both metabolic and structural 
changes in the retina because of its intimate association with all retinal cells and vasculature 
and with the space between the photoreceptor outer segments and pigment epithelium. 
Müller cells constitute an anatomical link between the retinal neurons and the 
compartments with which they need to exchange molecules, i. e., the retinal blood vessels, 
the vitreous body, and the subretinal space. This link is not merely anatomical but also 
functional. For this purpose, Müller cells are endowed with a wealth of different ion channels, 
ligand receptors, transmembraneous transporter molecules, and enzymes. Many of these 
molecules are not found in retinal neurons or other retinal cell types and are specifically 
expressed by Müller cells, or at least, are most abundant in Müller cells. (Newman and 
Reichenbach, 1996; Sarthy and Ripps, 2001) 
 
 
1.1.2.2  Fibrous Astrocyte 
 
Besides Müller cells, there is another macroglial cell, the astrocyte, in the retina. 
Astrocytes migrate into the retina via the optic nerve during embryogenesis and become 
located exclusively in the inner layers of the retina. Astrocytes are satellite in shape and their 
cell bodies are located in the ganglion cell layer. Their processes show no strict orientation. 
(Watanabe and Raff 1988) 
Astrocytes are widely dispersed between the vasculature and neurons. Morphologic and 
cytoplastic features of these cells allow them to be categorized into fibrous asytrocytes and 
protoplasmic astrocyte.(Bussow 1980) 
A fibrous astrocyte has a homogeneous cytoplasm with a dense round or oval nucleus, 
and a sparse endoplasmic reticulum. They contain a noticeable concentration of glycogen 
granules, elongated mitochondria, microtubules, a cilium, and an occasional centriole. 
(Kampik, Kenyon et al. 1981) 
On electron microscopy these cells are characterized by masses of intracytoplasmatic 
intermediate type 8- to 10-nm filaments and junctional complexes of the adherence type. 
Within the ganglion cell layer, the astrocytes tend to lie horizontally, surrounding the 
blood vessels. Their long, slender processes form interconnected honeycomblike scaffolding 
between vessels and neural cells. This network lies parallel to the interal limiting membrane 
and perpendicular to the Müller cells. The processes form an irregular pattern of 
interconnections with processes that reach over into the inner nuclear layer. There are no 
astrocytes centrifugal to the inner nuclear layer, so the outer plexiform and outer nuclear 
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layer has no astrocytes in the far peripheral retina or in the fovea. (Bussow 1980) 
 
1.1.2.3  Myofibroblast 
 
Myofibroblasts are well known as a cellular participant in wound-healing, a variety of 
inflammatory or fibrosing non-neoplastic conditions, and tumor growth. (Walshe, Esser et al. 
1992; Eyden, Banerjee et al. 2009) 
Myofibroblast share features with fibroblasts (rough endoplasmic reticulum, Golgi 
apparatus) and expression of smooth muscle actin. However they are devoid of lamina-α 
structure seen in smooth muscle cells. (Eyden, Banerjee et al. 2009) 
Myofibroblasts are of a spindled or satellite morphology, immunostaining for α-smooth 
muscle actin (α-SMA). Ultrastructure features of myofibroblasts are fusiform nucleus and cell 
body, rough endoplasmic reticulum, aggregate of 5-7nm subplasmalemmal cytoplasmic 
filaments, and the absence of intracytoplasmatic intermediate type 10 nm filaments or 
basement membran. (El-Labban and Lee 1983; Eyden, Banerjee et al. 2009) 
 
 
1.1.2.4  Fibroblast 
 
Fibroblasts are the main cells in the connective tissue. The cell synthesis collagen fibrils 
and often reside in close association with the collagen bundles. The cell has a dark stained, 
large and ovoid nucleus, and a well-defined nucleolus. Electron microscopy reveals a 
fusiform cell body and nucleus, abundant rough endoplasmic reticulum and a prominent 
golgi complex. (Krieg, Abraham et al. 2007) 
 
 
1.1.2.5  Macrophage 
 
Macrophages belong to the mononuclear phagocytic system. These cells are active 
phagocytes. Their functions are removing cellular debris and protecting the body against 
foreign invaders. (van Furth, Raeburn et al. 1979)  
Macrophages measure about 10-30 µm in diameter and are irregularly shaped. Active 
macrophages have pleats and folds in their plasma membrane as a consequence of cell 
movement and phagocytosis. Their cytoplasma contains many vacuoles and small dense 
granules. The nucleus is eccentric and usually has no nucleoli. Electron microscopy 
demonstrated an irregular shape of the nucleus, a well-developed Golgi apparatus, 
prominent rough endoplasmic reticulum, abundance of lysosomes, and multiple 
intracytoplasmatic vesicles. (Ryter 1985) 
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1.1.2.6  Retinal pigment epithelial cell 
 
The retinal pigment epithelium (RPE) cells are considered to be multifunctional 
pluripotent cells. The RPE has a polarization with a basement membrane. Each RPE cell is 
polarized with an apical part adjacent to the subretinal space and a basal portion facing 
Bruch's membrane. The cells are ultrastructurally characterized by intracytoplasmic melanin 
granules, microvilii and junctinal complexes. They extend from the margin of the optic disc to 
the ora serrata, where they are continuous with the pigmented epithelium of the pars plana 
of the ciliary body. (Gotzinger, Pircher et al. 2008) RPE cells have various functions. The 
essential one is the charge of metablism of photoreceptors. They are also related to vitamin 
A metabolism and regeneration in the visual cycle, phagocytosis and degradation of shed 
outer segment tips, light absorption by melanin granules, heat exchange, secretion of the 
matrix surrounding the photoreceptor inner and outer segments, and active transport of 
materials between the choriocapillaris and the subretinal space. (Strauss 2009) 
 
 
1.1.2.7  Hyalocyte 
 
Hyalocytes are distributed in the vitreous cortex in a single layer situated 20-50 µm away 
from the internal limiting membrane at the posterior retina and the basal lamina of the 
ciliary epithelium at the pars plana and vitreous base. (Sebag 1992) 
The ultrastructural features of hyalocytes have been described since the 1960s. These 
cells are oval or spindle-shaped, 10-15 µm in diameter, and contain a lobulated nucleus, a 
well-developed Golgi complex, smooth and rough endoplasmic reticula, and many large 
PAS-positive lysosomal granules and phagosomes. (Bloom and Balazs 1965) 
The main physiological functions of the hyalocytes are thought to be related to protein 
synthesis, e.g. hyaluronan synthesis, collagen synthesis, glycoprotein production and certain 
enzymes. (Sebag 1992) 
 
 
1.2  Pathogenesis of vitreoretinal diseases 
 
The intimate connection of the internal limiting membrane with the Müller cells 
suggests a common pathogenesis of the five vitreomacular interface diseases. The 
relationship of the internal limiting membrane to the cortical vitreous will produce a 
wrinkling of the retina if the membrane is affected by a cortical vitreous contraction. Besides 
the commonness, individual pathogenesis depends on the strength and the results of the 
traction force. 
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1.2.1  Macular holes 
 
Idiopathic macular holes are characterized by a dehiscence of the neuroretina at the 
fovea, leading to loss of central vision, metamorphopsia, and a central scotoma. (la Cour and 
Friis 2002) 
The majority of macular holes are primary idiopathic with a small proportion being a 
result of trauma, inflammation or high myopia. (McDonnell, Fine et al. 1982) 
 There were many theories on the pathogenesis of macular holes, such as 
anteroposterior vitreous traction bands (Lister 1924), age-related changes in the retinal 
vasculature leading to cystoid degeneration, responsible for atraumatic macular holes, 
vascular theory characterized as ocular angiospasm, and cystoid degeneration as the final 
common pathway towards macular hole formation. 
In 1988, Gass proposed a classification system for idiopathic macular holes, as well as a 
new hypothesis concerning their pathogenesis, suggesting that tangential vitreoretinal 
traction is responsible for macular hole formation. (Gass 1988) In 1995, Gass provided an 
updated biomicroscopic classification and anatomic interpretation of macular hole formation:  
(Gass 1995) 
Grade 1: The hole commences as a foveal intraretinal cyst (stage 1A) or ring of cysts 
(stage 1B) seen as a central yellow spot or ring of spots. The patient may be 
asymptomatic or have mild visual disturbances or image distortion. 
Grade 2: A small crescentic or round hole of less than 400 µm in diameter. 
Grade 3: A large round hole of more than 400 µm in diameter. 
Grade 4: A hole with an associated posterior vitreous detachment (PVD). 
(Gass 1988) 
 
The development of macular holes begins with a yellow spot or ring in the center of the 
fovea, and the fovea loses its depression. In some cases, spontaneous separation of the 
vitreous without macular hole formation may occur, in other cases, a pseudo-operculum 
appears above the hole. When the yellow spot or ring expanded, the initial break often 
occurred eccentrically near one edge of the ring, and it enlarged in a can-opener fashin over 
a period of weeks or several months to form initially a crescent-shaped macular hole, 
followed by a horseshoe-shaped macular hole, and finally by a round macular hole with an 
operculum attached to the posterior hyaloid surface. (Gass 1988) 
An ultrastructural study showed that fibrous astrocytes, myofibroblasts, fibroblasts, and 
macrophages were observed in descending order in ILM specimens obtained from patients 
with macular holes. Analysis of cellular distribution showed that mono- and multilayered 
cellular membranes were seen more frequently in stage IV macular holes than in stage III 
macular holes. The presence of native vitreous collagen was always associated with 
fibrocellular proliferation. (Schumann, Schaumberger et al. 2006) 
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1.2.2  Macular pucker 
 
Macular pucker is a term used for premacular membranes which cause macular surface 
distortion or visual impairment by membrane contraction. The exact pathogenesis of 
macular pucker remains unknown. The migration and proliferation of glial cells may play a 
predominant role. (Smiddy, Maguire et al. 1989) An epiretinal membrane forming a macular 
pucker may have more than one site of retinal contraction. (Gupta, Sadun et al. 2008)  
 
 
1.2.3  Vitreomacular traction syndrome 
 
Vitreomacular traction syndrome is characterized by a persistent attachment of the 
vitreous to the macula in eyes with an incomplete posterior vitreous detachment. (Gandorfer, 
Rohleder et al. 2002) The most common morphological configuration is a vitreous separation 
peripheral to a zone where the cortical vitreous remains attached to the retina at the macula 
and the optic nerve head. Ultrastructural investigation revealed that myofibroblasts were the 
predominant cell type. (Gandorfer, Rohleder et al. 2002) 
 
 
1.2.4  Diabetic retinopathy 
 
Diabetic retinopathy is characterized clinically by hemorrhages, microaneurysms, 
cotton-wool spots, lipid exudates, macular edema, capillary occlusion, and 
neovascularization. Neovascularization is the criterium for subdividing the disease into a 
nonproliferative and a proliferative form. Recent research indicates that diabetic retinopathy 
includes not only a microvascular but also a neuronal component.  
Müller cells have a direct effect in the formation of diabetic epiretinal membranes. 
Astrocytes were found undergoing severe changes in diabetics, such as the production of 
cytokines such as VEGF. (Barber, Antonetti et al. 2000) These cytokines can increase vessel 
permeability, (Cooper, Vranes et al. 1999) and act secondary on endothelial cells to reduce 
their ability to form tight junction. (Barber, Antonetti et al. 2000) 
Ultrastructural features of epimacular membranes from patients with proliferative 
diabetic retinopathy showed that the membranes were mostly multilayered consisting of 
predominantly fibroblasts and fibrous astrocytes situated on a layer of native vitreous 
collagen. Macrophages were present in most specimens; retinal pigment epithelial cells were 
not found. (Gandorfer, Rohleder et al. 2005) 
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1.2.5  Proliferative vitreoretinopathy 
 
Proliferative vitreoretinopathy (PVR) is characterized by the growth and contraction of 
cellular membranes within the vitreous cavity and on both retinal surfaces. It is not a specific 
clinical disease, but a consequence of a number of intraocular diseases with various stimuli 
such as retinal detachment and it is the major cause of failure of retinal detachment surgery. 
(Pastor, de la Rua et al. 2002)  
Lots of cells are implicated in the pathogenesis of PVR. Müller cells in fibroproliferative 
membranes may transdifferentiate into myofibroblasts that generate tractional forces in 
response to growth factors in the vitreous, thereby causing traction retinal detachment. 
(Guidry 2005)  
 Ultrastructural features of epiretinal membranes from patients with PVR showed that 
cell proliferation could be found in each specimen, and fibrous astrocytes, fibrocytes, 
macrophages and myofibroblast were the predominant cell types. (Kampik, Kenyon et al. 
1981) 
 
 
1.3  Surgical treatment 
 
1.3.1  Pars plana vitrectomy 
 
Par plana vitrectomy (PPV) is the most versatile surgical techniques to treat vitreoretinal 
disorders. It was performed by Machemer for the first time in the early 1970s. Later 
Machemer improved this technique with an intraocular fiberoptic light pipe and separated 
the probes for various functions.  
Kelly and Wendel introduced vitrectomy to close macular holes in 1991. The surgical 
technique consists of a pars plana vitrectomy and removal of the posterior hyaloid. Epiretinal 
membranes if present should be removed. The removal of ILM is also recommended to 
enhance the closure rate and functional outcome. A fluid-air exchange and an air-gas 
exchange follow. Face-down positioning is required for at least 4 days. (Kelly and Wendel 
1991)    
Some studies demonstrated a good outcome after vitrectomy with ILM-peeling in 
macular pucker eyes. (Park, Dugel et al. 2003; Kwok, Lai et al. 2005) In case of short duration 
the surgical treatment can obtain the best results.  
The vitreous hemorrhage caused by proliferative diabetic retinopathy is one of the most 
common indications for vitrectomy. Vitrectomy releases posterior vitreous traction which 
reduces the stimulus for retinal neovascularization. 
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1.3.2  Staining of the ILM 
 
The ILM is a translucent membrane. It is difficult to separate it from the retina without 
causing harm to the retina. Therefore, visualization of the ILM with vital dyes was 
recommended.  
The use of vital dyes to improve the visualization of intraocular tissues during vitrectomy 
has become a standard technique during vitrectomy. Recently this technique was named 
chromovitrectomy. (Rodrigues, Meyer et al. 2005)  
 
 
1.3.2.1  Different dyes  
 
  To improve the precision of ILM-peeling and to avoid incomplete removal, different vital 
dyes have been introduced. 
 
1.3.2.1.1  Indocyanine green 
 
The application of the indocyanine green (ICG) was firstly introduced in vitrectomy. ICG 
is a tricarbocyanine dye (C43H47N2NaO6S2, 775 daltons) and contains 3% to 5% iodine. It 
has good affinity to the ILM and induces a cleavage plane that facilitates removal of the ILM. 
(Farah, Maia et al. 2009)  
ICG-assisted vitrectomy was associated with high rates of macular hole closure in several 
series. However, there are reports on untoward effects of ICG in terms of visual outcome and 
peripheral visual field defects, and the dye is no more recommended in macular surgery. 
 
 
1.3.2.1.2  Trypan blue and membrane blue 
 
Trypan blue (TB)/membrane blue (MB) is a dye from anterior segment surgery which is 
used in vitrectomy now. It is an anionic hydrophilic azo dye (C34H24N6Na4O14S4, 
960daltons). Trypan blue has less affinity to the ILM compared with ICG, but it can stain 
cellular proliferations on the ILM sufficiently. (Farah, Maia et al. 2009) .  
 
 
1.3.2.1.3  Brilliant blue 
 
Brilliant blue (BB) is a blue anionic aminotriarylmethane compound (C47H48N3S2O7Na, 
854 daltons). It’s used in chromovitrectomy because of its selectively remarkable affinity for 
the ILM. It has been reported relatively safe because less toxic effect in animal research and 
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no toxic effect have been found in humans so far. (Farah, Maia et al. 2009) 
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2  MATERIALS AND METHODS 
 
2.1  Laboratory Equipment 
  
(1) +4 ℃ refrigerator (2) Incubator  
(BOSCH, Germany) (Memmert, Schwabach,Germany) 
 
  
 
 
 
 
(3) Electronic balance Scout Pro SPU 202  (4) Shaker IKA-VIBRAX-VXR  
(Ohaus, Pine Brook, NJ USA)  (IKA, Staufen, Germany) 
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(5) Stereomicroscope Leica MS5  (6) Captair®chem Filtair  
(Leica, Germany) (erlab) 
 
  
 
 
 
 
(7) Light microscope Leica DM2500  (8) Electron microscope Zeiss EM 9 S-2 
(Leica, Wetzlar, Germany) (Zeiss, Jena, Germany) 
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(9) Ultramicrotome Leica Ultracut R  
(Leica, Wien) 
  
 
 
 
2.2  Reagents 
 
Aqua dest (Braun 6724092) 
Na2B4O7 (Borax, MERCK 6306) 
1% CaCl2 (Pharmacy of Ludwig-Maxmilians University, C08) 
DDSA (SERVA 20755) 
DMP 30 (SERVA 36975) 
Epon 812 (SERVA 21045) 
Ethanol (MERCK 1.00983) 
25% Glutaraldehyde (Fluka 49626) 
K2Cr2O7 (Pharmacy of Ludwig-Maxmilians University) 
Lead citrate (Fluka 15334) 
MNA (SERVA 29452) 
3.4% NaCl (Pharmacy of Ludwig-Maxmilians University, N18) 
Na2HPO4 (MERCK 1.06346) 
NaH2PO4 (MERCK 1.06580) 
Osmium (Chempur 006051) 
PBS Buffer (Pharmacy of Ludwig-Maxmilians University, G09) 
1, 2-Propylenoxid (MERCK 1.12492) 
Sodium citrate (Sigma S-4641) 
1% Toluidine blue (Merck 115930) 
Uranyl acetate (TED PELLA INC. 19481) 
 
 
2.3  Prescription 
 
1) 0.1M PBS (phosphate buffered saline) 
Na2HPO4-2 H2O     14.42 g 
MATERIALS AND METHODS 
 
19 
 
NaH2PO4-H2O      2.62 g 
Distilled water to  1.0 l 
Adjust PH to 7.4 with HCl 
 
2) 4% Glutaraldehyde 
25% Glutaraldehyde    16 ml 
0.1M PBS to  100 ml 
 
3) 2% Osmium  
Osmium              1 g 
Aqua dest             50 ml 
Then place in the +4 ℃ refrigerator overnight 
 
4) 4% K2Cr2O7-KOH-bufffer 
K2Cr2O7               4 g   
Aqua dest             80 ml   
Adjust PH to 7.4 with KOH 5N 
Aqua dest            100 ml 
 
5) Dalton’s fixative 
2% Osmium                 20 ml 
4% K2Cr2O7-KOH-bufffer      10 ml 
3.4% NaCl                   4 ml 
1% CaCl2                    4 ml 
Aqua dest                   2 ml 
 
6) Epon 
Solution A    Epon 812       62 ml 
a) DDSA       100 ml 
Solution B   Epon 812        100 ml 
b) MNA        89 ml 
Solution A and B can be stored at -20 ℃ 
Before use, mix solution A and solution B with DMP 30: 
Solution A     9 ml 
Solution B     21 ml 
DMP 30       0.6 ml 
 
7) Mixture Propylenoxid+Epon 
1.2-Propylenoxid   20 ml 
Epon             20 ml 
Place at the room temperature overnight 
 
8) lead citrate 
Lead citrate  1.33 g          
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Sodium citrate 1.76 g 
Aqua dest.  30 ml 
stark shake for ca. 30 min     
add 8 ml 1 M NaOH slowly till the solution is clear 
add Aqua dest to 50 ml  
Then place in refrigerator overnight, sealed and prevent from light. 
 
 
2.4  Materials 
 
From a consecutive series of surgical ILM-specimens removed at the University Eye 
Hospital Munich between 1998 and 2008, 109 specimens were randomly chosen from 
preexisting semithin sections. Six of 103 patients underwent surgery on both eyes. We 
included 79 eyes with macular holes and 30 eyes with other traction maculopathies which 
comprised of 17 specimens from eyes with macular pucker, 4 specimens from eyes with 
diabetic tractional oedema, 3 specimens from eyes with proliferative vitreoretinopathy and 6 
specimens from eyes with vitreomacular traction syndrome. The surgical procedure was a 
standard three-port pars plana vitrectomy with peeling of the ILM and epiretinal tissue. 
Removal of the ILM was performed by experienced surgeons with and without intravitreal 
dye administration. Specimens without the ILM were excluded. Approval from the 
Institutional Review Board was obtained as well as the Informed Consent from each patient. 
The patients’ records were reviewed for age, gender, previous ocular surgery and 
preoperative history such as trauma. Additional information such as final best-corrected 
visual acuity, preoperative and postoperative status of the lens, and the period of follow-up 
examination was evaluated in those cases when cellular elements were seen at the retinal 
side of the ILM. 
The surgical procedure enclosed the induction of a posterior vitreous detachment, if 
necessary, by suction with the vitrectomy probe over the optic nerve head. Removal of the 
ILM was performed by grasping the ILM with an end-gripping forceps and peeling it off the 
macular area. No dye was administered to visualize the ILM in 74 cases, meanwhile in 35 
cases vital dye was administered. Trypan blue (Membrane blue, DORC, Netherlands) was 
used in 27 patients, brilliant blue (Brilliant peel, Geuder, Germany) was administered in 8 
surgeries. Both dyes were administered in the fluid filled globe at a volume of 0.1 to 0.2 ml 
and washed out immediately. In case of coexisting cataract, a combined procedure was 
performed. In eyes with macular holes, the vitreous cavity was filled with a mixture of 15% 
C2F6, and the patients were recommended to stay in face-down position for up to five days. 
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2.5  Methods 
 
  Figure 2- 1 
  
• specimens obtained from the surgery
• fixation
• washing
• postfixation
• washing
• dehydration
• transitional solvent
• embedding
• microtomy
• light microscopy
• electron microsopy
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2.5.1  Preparation  
 
The design of the project was to investigate all specimens with light microscopy. When 
large cellular fragments were found, electron microscopy was then performed. Therefore all 
specimens were processed by series sectioning for light microscopy. If cellular debris was 
present on the retinal side of the ILM, ultrathin sections were cut for transmission electron 
microscopy. 
The preparation may be divided into eight steps: primary fixation, washing, postfixation, 
dehydration, infiltration with transitional solvents, infiltration with resin, embedding, and 
curing. (Figure 2-1) 
 
 
2.5.1.1  Fixation 
 
The purpose of fixation is to preserve the structure of living tissue, theoretically with no 
alteration from the living state. Additionally, fixation should protect tissues against disruption 
during embedding and sectioning and exposure to the electron beam. 
Since all specimens were suitable for electron microscopy, glutaraldehyde was used as 
the fixative for all specimens, although formaldehyde penetrates tissue more readily than 
glutaraldehyde.  
Glutaraldehyde’s attribute as a fixative is in its ability to cross-link protein by virtue of 
the terminal aldehyde groups that make the molecule bifunctional. Specifically, the aldehyde 
groups react with ε-amino groups of lysine in adjacent proteins, thereby cross-linking them. 
The rate of penetration of glutaraldehyde into tissues is very slow. It can be expected to 
penetrate at a rate of less than 1 mm per hour if compact tissue is immersed into the 
glutaraldehyde. Therefore, the tissue should be under 1 mm in thickness at least in one 
dimension. This was the case in our series. 
The specimens harvested during vitrectomy were immediately placed in 
phosphate-buffered 4% glutaraldehyde solution. The fixation lasted at least 2 hours at +8℃.  
After fixation the specimens were washed in 0.1 M phosphate-buffer at PH 7.4 for 10-15 
minutes. 
 
 
2.5.1.2  Washing 
 
Aldehydes remaining from the primary fixation will be oxidized by osmium. Therefore, 
washing is important. It can eliminate free unreacted glutaraldehyde that remains within the 
tissues. The tissue is usually washed in the same buffer vehicle used for glutaraldehyde.  
 Unreacted glutaraldehyde will diffuse as slowly outward from the tissue as inward so 
that a minimum of a few hours of washing with changing buffer is recommended. 
Each specimen was washed 2 times and it took 10 minutes for each time.  
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2.5.1.3  Postfixation 
 
Standard glutaradehyde-osmium tetroxide protocal was developed in 1963. Primary 
fixation with glutaradehyde was followed by secondary exposure to osmium tetroxide.  
Osmium tetroxide works as a secondary fixative of tissue by reacting primary with lipid 
moieties. It is widely believed that the unsaturated bonds of fatty acids are oxidized by 
osmium tetroxide. This reduced heavy metal adds density and contrast to the biological 
tissue. The molecular weight of osmium tetroxide is sufficiently high to be effective in 
scattering electrons.  
The specimens were postfixated with Dalton’s fixative for 2 hours. 
 
 
2.5.1.4  Washing 
 
After postfixation, the specimens were again washed with 0.1 M phosphate buffer 2 
times. It took 10 minutes for each time. 
 
 
2.5.1.5  Dehydration 
 
Dehydration is the process of replacing the water in cells with a fluid that acts as a 
solvent between the aqueous environment of the cell and the hydrophobic embedding 
media. Ethanol is a common dehydrating agent. The specimens were dehydrated in graded 
concentrations of ethanol (30-50-70-90 and 100%) 2 times. Each time lasted 10 minutes. 
 
 
2.5.1.6  Transitional solvent 
 
Replacement of the dehydration solution by another intermediary solvent that is highly 
miscible with the plastic embedding medium is usually necessary to interface with the 
embedding media. The standard solvent used is propylene oxid, a highly volatile and a 
potentially carcinogenic liquid. It will also further dehydrate the tissue.  
The specimens were placed in propylene oxid for 10-20 minutes. Then the specimens 
were placed in a mixture of propylene oxid and Epon at room temperature overnight. 
 
 
2.5.1.7  Embedding 
 
All specimens were embedded in Epon. Epon is the brand name of Epoxy embedding 
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media, which was introduced as an embedding medium by Glauert and subsequently 
modified by Luft. The hardness of the Epon mixture is controlled by the relative amount of 
DDSA (Dodecenylsuccinic anhydride) and NMA (Methyl Nadic anhydride), the former 
producing softer blocks and the latter harder blocker. The solution must be thoroughly mixed 
in a disposable plastic beaker using a resin mixer, a glass rod. The process can be accelerated 
by DMP (2, 4, 6-Tris (dimethylaminomethyl) phenol). The accelerator is added and mixed 
with the above.  
The final step in embedding is curing the tissue blocks. With epoxy resins, a chain of 
polymerized resin is formed that crosslinks to other chains of resins to form an intergrated 
meshwork that totally permeates the tissue. Increased temperature accelerates the rate of 
hardening. Then the mixture was placed at +60 ℃ for 24-48 hours to polymerize. 
 
 
2.5.2  Microtomy and Light microscopy 
 
Light microscopy was performed in all 109 specimens. Series semithin sections of 1000 
µm were cut by ultramicrotome Leica Ultracut R (Leica, Wien). The section was placed on a 
glass slide and stained with an aqueous mixture of 1% toluidine blue and 2% sodium borax. 
Overall, 1379 sections of 109 specimens were evaluated by light microscopy (mean value 
12.7 sections per specimen).  
Tissue sections were analyzed using a Leica light microscope (Leica, Wetzlar, Germany). 
The morphologic features of both the vitreal and the retinal side of the ILM were evaluated 
in terms of cell distribution, number of cells, and collagen distribution. 
 
 
2.5.3  Electron microscopy 
 
If cellular debris was present on the retinal side of the ILM, specimens were prepared 
for transmission electron microscopy. Ultrathin sections of 60-70nm were cut by 
ultramicrotome Leica Ultracut R (Leica, Wien). A Diamond Knive was used for ultramicrotomy. 
The sections were floated in distilled water and captured by a copper grid. From each 
specimen, serial sections of five grids with nine ultrathin sections were obtained. The 
ultrathin sections were contrasted with uranyl acetate for 15 minutes and with lead citrate 
for 10 minutes at room temperature. 
A Zeiss EM 9 S-2 electron microscope was used for electron microscopy. Type and 
location of the cells, their relationship to the ILM, status of intracytoplasmatic organelles 
such as nucleus, intracellular filaments and intracellular vesicles were documented. 
The cellular elements on the retinal side of the ILM were quantified according to four 
groups as follows:  
1) small (<1 µm in diameter) and solitarily distributed round cell fragments,  
2) medium sized (1-2 µm in diameter) and accumulated round cell fragments,  
3) large cell fragments (>2 µm in diameter),  
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4) complete cell bodies with cellular organelles.  
 
 
2.5.4  Statistical Analysis 
 
Statistical analysis of data was performed using the computer software (Statistical 
Package for the Social Science (SPSS) version 16.0).  
Spearman rank correlation coefficient test, Pearson Chi- square test and Fisher’s exact 
test were performed to evaluate the relationship between the presence of cell fragments on 
the retinal side and on the vitreal side, the relationship between the group with and without 
dye administration, and the relationship between macular hole and other retinopathies. 
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3  RESULTS 
 
3.1  Clinical features 
 
Forty-three right eyes and 66 left eyes were included in this series, corresponding to 76 
woman and 33 men. Six patients underwent surgery on both eyes. The average age at time 
of surgery was 63.7 years (range 10 to 84 years). (Table 3 - 1) The age distribution of patients 
was as follows: <50 years (n=12), 50-60 years (n=17), 61-70 years (n=46), 71-80 years 
(n=30), >80 years (n=4). (Table 3 - 1)  
The patients were divided into two groups: without vital dye and with vital dye 
administration. Each group contained two kinds of retinal diseases: macular hole and at least 
one kind of other maculopathies which included macular pucker, diabetic retinopathy, 
proliferative retinopathy and vitreomacular traction syndrome. In detail, we included 3 eyes 
with stage II macular holes, 24 eyes with stage III macular holes, 5 eyes with stage IV macular 
holes, 13 eyes with recurrent macular holes, 8 eyes with secondary macular holes (due to 
trauma or associated with retinal detachment), 6 eyes with primary macular pucker, 5 eyes 
with secondary macular pucker (after previous vitrectomy for retinal detachment), 1 eye 
with diffuse macular edema in proliferative diabetic retinopathy, 3 eyes with proliferative 
vitreoretinopathy and 6 eyes with vitreomacular traction syndrome in the group without dye 
administration; and in the group with dye administration, we included 2 eyes with stage II 
macular holes, 9 eyes with stage III macular holes, 6 eyes with stage IV macular holes, 6 eyes 
with recurrent macular holes, 3 eyes with secondary macular holes (due to trauma or 
associated with retinal detachment), 4 eyes with primary macular pucker, 2 eyes with 
secondary macular pucker (after previous vitrectomy for retinal detachment) and 3 eyes with 
proliferative diabetic retinopathy. (Table 3 - 2) 
Only two types of vital dyes were selected in this study: membrane blue and brilliant 
blue. In 35 specimens with dye administration, we included 27 specimens with membrane 
blue and 8 specimens with brilliant blue. (Table 3 - 2) 
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3.2  Morphological features 
 
3.2.1  Light microscopic features 
 
1379 slices of 109 specimens were evaluated by light microscopy (mean value 12.7 slices 
per specimen). 
Light microscopic examination showed the ILM as a continuous strand in all 109 
specimens in low magnification (Figure 3 - 1). In higher magnification, two sides of the ILM 
could be distinguished by their different morphological characteristics: the retinal side of the 
ILM was undulated, and the vitreal side of the ILM was smooth (Figure 3 - 2). Cell debris or 
complete cells were observed on both sides of the ILM. In both groups of specimens, and in 
all five retinal diseases, cellular elements could be found on both sides of the ILM. Collagen 
was observed only on the vitreal side of the ILM. The morphologic features of both the 
vitreal and the retinal side of the ILM were evaluated in terms of cell distribution, number of 
cells, and collagen distribution. (Table 3 - 3, Table 3 - 4)  
 
 
3.2.1.1  Vitreal side of the ILM 
 
On the vitreal side of the ILM, cells or cell fragment could be found directly attached to 
the ILM, or with collagen between cells and ILM.  
Cells on the vitreal side of the ILM were arranged in a single-, mono- or multilayer. In 
this study, fibrocellular proliferation on the vitreal side of the ILM was seen in 41 specimens 
in the group without dye administration and in 20 specimens in the group of dye 
administration. In the group without dye administration, 32 specimens showed single cells 
and 9 cases presented with a mono- or multilayered cellular proliferation (Table 3 - 3), 
meanwhile in the dye administration group, 15 specimens showed single cells and 5 
specimens presented with a mono- or multilayered cellular proliferation on the vitreal side of 
the ILM. (Table 3 - 4)  
Collagen which was found on the vitreal side of the ILM was located between the ILM 
and cells. There are two distribution types of the collagen on the vitreal side of the ILM: 
focally present or present in a continuous strand. (Figure 3 - 3) In the group without dye 
administration, 10 specimens presented focal collagen and 2 specimens presented 
continuous collagen. (Table 3 - 3) In the dye administration group 9 specimens presented 
with focal collagen and 1 specimen presented continuous collagen. (Table 3 - 4) 
In 32 specimens in the group without dye administration and in 15 specimens in the dye 
administration group, cells and collagen were absent. 
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3.2.1.2  Retinal side of the ILM 
 
Complete retinal cells and large retinal cell fragments were found in 16 specimens at the 
ILM by light microscopy in the group without dye administration, which composed of 8 
specimens from macular hole, 4 specimens from macular pucker, 1 specimen from diabetic 
maculopathy, 1 specimen from proliferative vitreomacular retinopathy and 2 specimens from 
vitreomacular traction syndrome. (Table 3 - 3) In the dye administration group 9 specimens 
were found on the retinal side of the ILM by light microscopy, which composed of 6 
specimens from macular hole, 2 specimens from macular pucker and 1 specimen from 
diabetic maculopathy. (Table 3 - 4) 
 The retinal cell elements presented with single cells only. (Figure 3 – 5, Figure 3 – 6) No 
mono- or multilayer was found on the retinal side of the ILM.  
Besides complete cells or large cell fragments, small cell fragments were also found on 
the retinal side of the ILM. No collagen was present on the retinal side of the ILM. 
 
 
3.2.1.3  Single cells crossing the ILM 
In 109 specimens, three cells in 2 specimens were found crossing the ILM. One 
specimen with 2 cells crossing the ILM was from a patient with recurrent macular hole 
without dye administration. (Figure 3 – 7) Another case that showed a single cell crossing the 
ILM was from patient with stage IV macular hole with brilliant blue administration.  
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3.2.2  Electron microscopic features 
 
3.2.2.1  ILM in electron microscopy 
 
Ultrastructural evaluation focused on the 25 specimens that showed cells or cellular 
debris on the retinal side of the ILM. In each specimen that was found with retinal cellular 
elements at the ILM, the presence of retinal cell fragments or retinal cell bodies could be 
confirmed in ultrathin sections. (Figure 3 - 8) 
 
 
3.2.2.2  Four distinct morphologic patterns of retinal structures 
 
Four distinct morphologic patterns were observed on the retinal side of the ILM that 
were quantified as follows:  
(1) Small (<1 µm in diameter) round cell fragments were solitarily distributed and mostly 
directly adjacent to the ILM. The cell fragments resembled plasma membrane remnants 
of Müller cell endfeet, and they often appeared disrupted and electrondense with direct 
contact to the undulations of the ILM. (Figure 3-9) 
(2) Medium sized (1-2 µm in diameter) round cell fragments were found with and without 
contact to the ILM. Their electron density was variable. Therefore, the cell fragments 
appeared to originate from different structures such as Müller cell endfeet, optic nerve 
fibers, or ganglion cell remnants. (Figure 3-10) 
(3) Large cell fragments of more than 2 µm in diameter were frequently found surrounded 
by smaller cell fragments with multiple remnants of plasma membranes. They appeared 
to originate from Müller cell endfeet and Müller cell processes as well as from optic 
nerve fiber bundles. (Figure 3-11) 
(4) Entire retinal cell bodies with cellular organelles such as nucleus, mitochondria, 
intracytoplasmatic vesicles and filaments were seen in direct contact to the ILM. (Figure 
3-12) 
 
 
3.2.2.3  Pattern of cellular elements depending on the disease in 
the group without dye administration 
 
In the group without dye administration, specimens from eyes with macular holes 
showed retinal cell debris mainly of medium or large size, whereas specimens from eyes with 
other traction maculopathies mostly presented with large cell fragments or complete retinal 
cells. (Table 3 - 8) 
In specimens removed from macular holes eyes, retinal cell fragments were mostly 
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smaller than those from eyes with other traction maculopathies. Large retinal cell bodies 
were seen in 63% of all eyes with macular holes. Large retinal cell bodies and complete 
retinal cell were seen in 88% of eyes with other traction maculopathies. Complete retinal cell 
bodies were not seen in eyes with macular holes, but in 63% of eyes with other traction 
maculopathies. 
 
 
3.2.3  Comparison between different groups 
 
3.2.3.1  Cell proliferation 
 
To investigate whether the retinal damage was correlated with the vitreal cellular 
proliferation, the presence of cell debris on both sides of the ILM was evaluated.  
In all 109 specimens, cells or cell fragments were found in 61 specimens on the vitreal 
side and in 25 specimens on the retinal side of the ILM. Among the 25 specimens that 
showed retinal cells at the ILM, 18 specimens (72.0%) showed vitreal cells at the same time. 
In contrast, among the 61 specimens that presented without vitreal cell fragments, retinal 
debris were seen in 18 (29.5 %) specimens. (Table 3 - 5) 
Spearman rank correlation coefficient test/Pearson Chi- square test was performed to 
evaluate whether the presence of cell fragments on the retinal side was related to the 
presence of cell proliferation on the vitreal side. No significant correlation was seen between 
the presence of retinal cells and vitreal cells. (Spearman rank correlation coefficient test P = 
0.067, Pearson Chi- square test P = 0.066) 
  
 
3.2.3.2  Dye administration 
 
To investigate whether the cellular presence on the retinal side of the ILM was 
correlated with dye administration, the retinal cell debries in patients with idiopathic 
macular holes and idiopathic macular pucker in the group with and without dye 
administration was evaluated. 
In the group without dye administration, retinal cells were found in 5 specimens (13.2%) 
and were not found in 33 specimens. In the group with dye administration, retinal cells were 
found in 8 specimens (38.1%) and were not found in 13 specimens. A significant difference 
was seen between the presence of retinal debris between the two groups. (Pearson Chi- 
square test P = 0.027) (Table 3 - 6) 
 
 
3.2.3.3  Diseases 
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To investigate whether the presence of retinal cell fragments depended on the 
underlying disease, specimens of macular hole patients and specimens with other 
maculopathies were evaluated. 
In the group without dye administration, retinal cell fragments were found in 8 
specimens (15.1%) of macular holes and 8 specimens (38.1%) of other maculopathies. There 
was significantly less retinal cell debris in macular holes than in other traction maculopathies 
such as macular pucker, vitreomacular traction syndrome, diabetic retinopathy, and 
proliferative vitreoretinopathy (Pearson Chi- square test P=0.030). (Table 3 - 7) 
In the group with dye administration, retinal cell fragments were found in 6 specimens 
of macular holes and in 3 specimens with other maculopathies. No significant difference was 
seen between macular holes and other traction maculopathies. (Fisher’s exact test P=0.665) 
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Figures and tables 
Figure 3 - 1 ILM in low magnification 
 Figure 3- 1: Light microscopy of semithin section showing an entire specimen. The ILM was stained blue with a mixture of 1% toluidine blue and 2% sodium borax.  (Original magnification: 10x) 
 
Figure 3 - 2 ILM in high magnification 
 Figure 3- 2: Light microscopy of ILM stained with a mixture of 1% toluidine blue and 2% sodium borax. The ILM (asterisk) was showing a smooth vitreal side (arrowhead) and an undulating retinal side (long arrow). Two cells with a complete cell nucleus (short arrow) were present on the retinal side of the ILM. (Original magnification: 100x)  
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Figure 3 - 3 Singel cell on the vitreal side 
 Figure 3- 3: Light microscopy of the ILM stained with the mixture of 1% toluidine blue and 2% sodium borax. A single cell (arrow), which was present on the vitreal side of the ILM, was separated from the ILM (asterisk) by a continuous strand of collagen fibers (arrowhead). (original magnification: 100x)     
 
Figure 3 - 4 Mono-/multilayer on the vitreal side 
 Figure 3- 4: Light microscopy of the ILM stained with the mixture of 1% toluidine blue and 2% sodium borax. A mono-/multilayer (arrowhead) was present on the vitreal side of the ILM (asterisk). (Original magnification: 40x)     
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Figure 3 - 5 Singel cell on the retinal side 
 Figure 3- 5: Light microscopy of the ILM from a patient with stage IV macular hole. A single cell (arrow) was present on the retinal side (arrowhead) of the ILM (asterisk). (Original magnification: 100x)    
 
Figure 3 - 6 Cells on the retinal side 
 Figure 3-6: Light microscopy of the ILM from patient with proliferative vitreoretinopathy. Two single cells (short arrow) were present on the retinal side (arrowhead) of the ILM (asterisk). (Original magnification: 40x)    
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Figure 3 - 7 Cell crossing the ILM 
 
 
 Figure 3-7: Light microscopy of the ILM from patient with persistent macular hole. A cell (arrow) on the retinal side (arrowhead) crossing the ILM (asterisk). (Original magnification: 100x)     
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Figure 3 - 8 The presence of retinal cell fragments in light- and 
electronmicroscopy 
 
 
 Figure 3-8: Left, light micrographs (LM) and, right, transmission electron micrographs (TEM) of the internal limiting membrane (ILM) (asterisk) removed from eyes with diabetic macular edema, stage IV idiopathic macular hole, and proliferative vitreoretinopathy (from top to bottom). The ILM is characterized by an undulated retinal side and a smooth vitreal side. 
 (Top) Plasma membrane fragments (arrow) on the retinal side of the ILM. The vitreal side of the 
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ILM (arrowhead) is devoid of cells and collagen. (specimen removed for diabetic macular edema, 
original magnification: LM 40x; TEM x9500, bar=1.0 μm)  (Middle) LM shows a cell with nucleus on the retinal side of the ILM, EM shows one large cell fragment (arrow) in contact with ILM (asterisk), and a single cell on the vitreal side of the ILM (arrowhead) which shares features with fibrous astrocytes such as masses of intermediate type filaments, rough endoplasmic reticulum and electrondense particles. (specimen removed for 
stage IV idiopathic macular hole, original magnification: LM 100x; TEM x4800, bar=2.0 μm)  (Bottom) Entire cell body with cellular nucleus (arrow) located on the retinal side of the ILM (asterisk). The vitreal side of the ILM (arrowhead) is blank. (specimen removed for proliferative vitreoretinopathy, original magnification: LM 100x; TEM x9500, bar=1.0 μm) 
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Figure 3 - 9 Morphologic pattern 1 
 
  Figure 3- 9: Electron microscopy of the ILM (asterisk) from a patient with persistent macular hole showing small (< 1 µm in diameter) and solitarily distributed round cell fragments (arrow) on the retinal side of the ILM. (original magnification: x9500, bar=1.0 µm) 
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Figure 3 - 10 Morphologic pattern 2 
 
  Figure 3- 10: Electron microscopy of the ILM (asterisk) from a patient with persistent macular hole showing medium sized (1-2 µm in diameter) round cell fragments (arrow) (original magnification: x4800, bar=2.0 µm) 
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Figure 3 - 11 Morphologic pattern 3 
 
  Figure 3- 11: Electron microscopy of the ILM (asterisk) from patient with vitreomacular traction syndrome showing a ruptured cell with a cell nucleus (arrowhead) and multiple remnants of plasma membranes (arrow). The nucleus is round and regular, contoured with fine granules of chromatin. It is approximately 3 µm in diameter. (original magnification: x4800, bar=2.0 μm) 
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Figure 3 - 12 Morphologic pattern 4 
 
  Figure 3- 12: Electron microscopy of the ILM (asterisk) from a patient with proliferative vitreoretinopathy showing a complete cell with cell nucleus (arrow) with approximately 10 µm in diameter on the retinal side of the ILM. The irregular contoured, undulated nucleus was presenting with nucleoli and chromatin mostly distributed along the caryomembrane. Its plasma membrane fills the undulations of the ILM and the cytoplasm is found with abundant mitochondria (arrowhead), endoplasmatic reticulum and golgi complexes.  
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Table 3 - 1 Clinical Features 
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Table 3 - 2 Number of the specimens  
 
Diagnose Without dye 
administration 
With dye 
administration 
total 
BB MB 
Macular 
holes  
stage II 3 2  5 
stage III 24  9 33 
stage IV  5 3 3 11 
recurrent 13  6 19 
secondary 8  3 11 
macular 
pucker 
primary 6 3 1 10 
secondary 5  2 7 
proliferative diabetic 
retinopathy 
1  3 4 
proliferative 
vitreoretinopathy 
3   3 
vitreomacular 
traction syndrome 
6   6 
 
total 
74 35 109 
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Table 3 - 3 Evaluation of specimens without dye administration by light microscopy 
Diagnosis 
 
number 
of 
specimen
s 
Cells on vitreal side of the ILM 
Vitreal 
collagen 
Cells on retinal side of the ILM 
single 
cell 
Mono/
multilay
er 
total single cell total 
macular 
holes 
macular hole stage II 3 
53 
0 0 0 
25 
0 0 
8 
macular hole stage III 24 11 2 13 2 2 
macular hole stage IV 5 2 1 3 1 2 
Recurrent macular hole 13 5 3 8 1 3 
Secondary macular 
hole 
8 1 0 1 1 1 
macular 
pucker 
Primary macular pucker 6 
11 
4 0 4 
16 
2 1 
4 
8 
Secondary macular 
pucker 
5 4 0 3 1 3 
Diabetic retinopathy 1 1 1 0 1 0 1 1 
Proliferative vitreoretinopathy 3 3 2 0 2 1 1 1 
Vitreomacular traction syndrome 6 6 2 3 6 3 2 2 
total 74 32 9 41 12 16 
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Table 3 - 4 Evaluation of specimens with dye administration by light microscopy  
Diagnosis 
 
number 
of 
specimen
s 
Cells on vitreal side of the ILM 
Vitreal 
collagen 
Cells on retinal side of the ILM 
single 
cell 
Mono/
multilay
er 
total single cell total 
macular 
holes 
macular hole stage II 2 
 
0 1 1 
15 
0 2 
6 
macular hole stage III 9 3 1 4 3 1 
macular hole stage IV 6 2 1 3 2 3 
Recurrent macular hole 6 3 2 5 3 0 
Secondary macular 
hole 
3 2 0 2 1 0 
macular 
pucker 
Primary macular pucker 4 
 
2 0 2 
5 
1 2 
2 
3 
Secondary macular 
pucker 
2 1 0 1 0 0 
Diabetic retinopathy 3  2 0 2 0 1 1 
Proliferative vitreoretinopathy /  / / / / /  
Vitreomacular traction syndrome /  / / / / /  
total 35 15 5 20 10 9 
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Table 3 - 5 Presence of cellular elements on the retinal and vitreal 
side of the ILM in all specimens 
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Table 3 - 6 Presence of retinal cell elements in patients with 
idiopathic macular holes and macular pucker 
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Table 3 - 7 Presence of retinal cell elements depending on the 
disease in the group without dye administration 
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Table 3 - 8 Four patterns of cellular elements on the retinal side of 
the ILM in the group without dye administration 
 
Patterns of 
cellular 
elements 
Macular holes Other traction maculopathies 
idiopathic reccurent secondary MP DR  PVR VMTS 
small 1       
medium 1 1  1    
large 2 2 1 2    
complete cell    1 1 1 2 
Total number 
(%) of the 
case 
4/32 
(12.5%) 
3/13 
(23.1%) 
1/8 
(12.5%) 
4/11 
(36.4%) 
1/1 
(100%) 
1/3 
(33.3%) 
2/6 
(33.3%) 
 MP: macular pucker DR: diabetic retinopathy PVR: proliferative vitreoretinopathy VMTS: vitreomacular traction syndrome 
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4  DISCUSSION 
 
4.1  Principal findings 
 
4.1.1  Morphologic changes on both sides of the ILM 
 
The ILM plays a role as a structural boundary between the vitreous and the retina. It has 
a smooth vitreal surface and an irregular retinal surface, due to its close apposition with the 
plasma membrane of the Müller cell endfeet.  
Given the close anatomic relationship, removal of the ILM may damage inner retinal 
layers. The structural evidence of retinal cell fragments in surgical ILM specimens can be 
interpreted as an indicator for retinal changes induced by vitreoretinal surgery, especially by 
peeling of the ILM. 
In the present study, retinal fragments of ILM removed by vitreoretinal surgery were 
observed in 16 specimens without vital dye administration and in 9 specimens with dye 
administration. In these 109 specimens, we included macular hole patients, and other 
maculopathies such as macular pucker, diabetic retinopathy, proliferative vitreoretinopathy 
and vitreomacular traction syndrome. The retinal damage was evaluated in three aspects: 
cell fragments on both sides of the ILM were observed to evaluate if the retinal damage was 
related to the vitreal cell proliferation, i.e. to the underlying disease; cell fragments in 
patients with idiopathic macular holes and idiopathic macular pucker were investigated in 
the group with and without dye administration (birilliant blue and membrane blue), in order  
to evaluate if the retinal changes were related to the administration of vital dyes. 
The answers to the questions were:  
1. Cell fragments were found in 25 specimens on the retinal side of the ILM and in 61 
specimens on the vitreal side of the ILM by light microscopy. No significant 
correlation was seen between the presence of retinal cells and vitreal cells;  
2. When comparing eyes with idiopathic macular holes and macular pucker, retinal 
cells were found in 5 specimens (13.2%) in the group without dye administration, 
and in 8 specimens (38.1%) in the group with dye administration. There was a 
significant difference between the two groups.  
3. In the group without dye administration, retinal cell fragments were found in 8 
specimens (15.1%) of macular holes and 8 specimens (38.1%) of other 
maculopathies. There was significantly less retinal cell debris in macular holes than 
in other traction maculopathies such as macular pucker, diabetic retinopathy, 
proliferative vitreoretinopathy and vitreomacular traction syndrome; in the group 
with dye administration, retinal cell fragments were found in 6 specimens of 
macular holes and in 3 specimens of other maculopathies. No significant difference 
was seen between macular holes and other traction maculopathies when dye was 
used. 
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Concerning the potential origin of retinal cells and cell fragments at the ILM, small cell 
debris found on the retinal side of the ILM in the present study as well as in previous 
investigations may correspond to fragments of retinal structures attached to the ILM such as 
Müller cell endfeet, or disrupted nerve fiber.  
In accordance with precious work of our group, small fragments of the Müller cell 
plasma membrane were found on the retinal side of the ILM in all specimens. Entire cell 
bodies of retinal cells were primarily found in patients with other traction maculopathies 
than macular holes, and in patients with additional dye application. 
 
 
4.1.2  Explaining of the results 
 
In this study, we collected two groups of specimens, those without vital dye 
administration and those with Membrane Blue/Brilliant Blue administration. To avoid the 
influence of other confounding factors, we compared the presence of retinal cells between 
the two groups only in idiopathic macular holes and idiopathic macular pucker specimens. 
Significant less retinal cell fragments were seen in the group without dye administration.  
We included five diseases in the group without dye administration: macular holes, 
macular pucker, diabetic retinopathy, proliferative vitreoretinopathy and vitreomacular 
traction syndrome. The results in this study showed significantly less retinal cell debris in 
macular holes than in the other traction maculopathies. Previous research suggested that 
both vitreous traction and cellular proliferation play an essential role in the pathogenesis of 
all these five disease. For macular holes, tangential vitreoretinal traction is the initial cause of 
macular hole development, cell migration and cell proliferation on both sides of the ILM 
appear to be a secondary event. (Schumann, Schaumberger et al. 2006) For the other four 
diseases, cell proliferation and epiretinal membrane formation are primary changes resulting 
in epimacular cellular proliferation. (Gandorfer, Messmer et al. 2000; Gandorfer, Rohleder et 
al. 2002; Gandorfer, Rohleder et al. 2005)  
To qualify retinal cells or cell fragments, four morphological patterns were chosen with 
respect to different size of the retinal debris. Specimens from eyes with macular holes 
showed retinal cell debris mainly of medium or large size, whereas specimens from eyes with 
other traction maculopathies mostly presented with large cell fragments or complete retinal 
cells. 
 
 
4.2  Strengths and weaknesses of the study 
 
This is the first study on retinal elements adherent to the ILM following surgery in a 
large series. The study provides the morphological changes on both sides of the ILM after 
surgery in 5 diseases with and without dye assistance. 
The study’s main limitation is due to the conventional preparation procedure for 
electron microscopic analysis. Only cross sections of ILM specimens were observed that were 
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obtained by series sectioning. However, there is no more accurate evaluation of cell 
proliferation at the ILM than transmission electron microscopy. Recently, a new preparation 
procedure for light microscopy and interference microscopy proposed flat mounted ILM 
specimens for cell quantification, but a differentiation between the vitreal side and the 
retinal side of the ILM would not have been possible with this technique. (Gandorfer, Scheler 
et al. 2009)  
The relatively small number of other traction maculopathies compared with the number 
of macular holes is another limitation of this study, because the cases of other 
maculopathies are not so frequent as cases of macular holes. 
 
 
4.3  Strengths and weaknesses in relation to other studies 
 
By light microscopy of series sections, 109 ILM specimens were screened. Retinal cell 
debris were found in 25 cases. By transmission electron microscopy, these 25 ILM specimens 
mostly showed large retinal cell fragments of more than 2 µm in diameter as well as entire 
retinal cells. The presence of retinal cell remnants at the ILM appeared to depend on the 
underlying disease when no dye applied. Large cell fragments and complete retinal cells 
were seen more often in traction maculopathies other than macular holes. In macular holes, 
15.1% of the ILM specimens without dye administration were found with cellular remnants 
on the retinal side of the ILM. This is consistent with results of a study on the ultrastructure 
of stage III and IV idiopathic macular holes removed without dye assistance when 12 (13%) of 
92 cases were seen with retinal cell debris. (Schumann, Schaumberger et al. 2006) However, 
the latter study only found small cell fragments whereas this study showed large cell 
fragments and complete retinal cells in 63% of all macular holes including idiopathic macular 
holes as well as recurrent macular holes. 
The herein demonstrated small and medium sized round retinal cell fragments were 
identified as plasma membrane of Müller cells and fragments of Müller cell endfeet. Similar 
structures have already been reported in other studies. Haritoglou reported round structures 
on the retinal side of the ILM in patients with macular holes after conventional peeling of the 
ILM during the surgery. These round structures are supposed to represent inner potions of 
the Müller cells torn away with the ILM. In comparison with undulated areas of the retinal 
side of ILM, only very tiny cellular fragments can be seen in areas where the retinal surface 
of the ILM appears smooth. (Haritoglou, Schumann et al. 2006) Tari reported a similar 
structure with transport vesicles in it and indicated that the structures were Müller cell end 
feet. (Tari, Vidne-Hay et al. 2007) 
Several studies assumed that retinal cell remnants at the ILM originate from Müller cell 
footplates which directly insert at the characteristic undulations of the retinal side of the ILM. 
(Sebag 1992; Smiddy, Feuer et al. 2001; Wolf, Schnurbusch et al. 2004; Schumann, 
Schaumberger et al. 2006)  
Large retinal cell fragments and complete retinal cells in ILM specimens removed 
without dye assistance appear to originate not exclusively from Müller cells. Some 
ultrastructural characteristics of these cells such as round and regular nuclei, fine granules of 
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chromatin may be attributed to astrocytes and occasionally to oligodenroglia. (Villegas 1964) 
Whole retinal cells with electrodense nuclei found at the ILM may present cells of still 
unknown origin. A similar phenotype of cells has recently been found following a 
multilayered glial cell proliferation underneath the ILM in eyes with macular pucker. 
(Haritoglou, Schumann et al. 2007) 
 
 
4.4  Meaning of the study 
 
The exact mechanisms of the pathogenesis of cellular proliferation on both sides of the 
ILM are still unclear. Given the close anatomic relationship, removal of the ILM may change 
the architecture of inner retinal layers. The structural evidence of retinal cell fragments in 
surgical ILM specimens can be interpreted as an indicator for retinal changes induced by 
vitreoretinal surgery. Since large cellular remnants on the retinal side of the ILM were seen 
after ILM removal with intravitreal administration of ICG (Gandorfer, Haritoglou et al. 2001; 
Haritoglou, Gandorfer et al. 2002; Schumann, Schaumberger et al. 2006; Schumann, 
Gandorfer et al. 2009), this study was primarily conducted to evaluate the presence of large 
retinal cell fragments in ILM specimens removed without dye assistance. 
Müller cells are thought to play a key role in the maintenance of retinal homeostasis and 
function. (Newman and Reichenbach 1996; Newman 2004; Metea and Newman 2007) They 
significantly modulate neuronal activity by controlling the concentration of neuroactive 
substances. (Szatkowski, Barbour et al. 1990) Thus, the adherence of Müller cell fragments at 
the ILM during ILM removal might induce neurosensory retinal damage. This hypothesis is 
supported by reports on transient b-wave depressions in focal macular electroretinograms 
and visual field defects after ILM-peeling in macular hole surgery. (Haritoglou, Ehrt et al. 
2001; Terasaki, Miyake et al. 2001) 
By electron microscopy, Wolf and colleagues demonstrated structural damage of inner 
retinal layers following ILM peeling. (Wolf, Schnurbusch et al. 2004) In human donor retina, a 
substantial number of Müller cell endfeet and Müller cell processes were severely damaged 
even at the margins of the peeled area. However, these human donor eyes were peeled with 
ICG assistance. There is evidence that ILM peeling with intravitral ICG administration in 
macular surgery may have worse functional outcomes caused by ICG related retinal toxicity. 
(Gandorfer, Haritoglou et al. 2001; Gandorfer, Haritoglou et al. 2003; Gass, Haritoglou et al. 
2003; Haritoglou, Gandorfer et al. 2003; Ando, Sasano et al. 2004; Rodrigues, Meyer et al. 
2007) The dye-related retinal toxicity may act as a multifactorial process that may include an 
alteration of the cleavage plane by changing the biomechanical features of the ILM. 
(Haritoglou, Gandorfer et al. 2002; Gandorfer, Haritoglou et al. 2003; Wollensak, Spoerl et al. 
2004) 
In the context of mechanical damage and dye-related toxicity, the present study could 
serve as a basis to compare the presence of retinal fragments after ILM peeling with 
administration of novel dyes. 
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4.5  Unanswered questions and future research 
 
Although this study gave us some basement data to suggest the origin of cell 
proliferation on both sides of the ILM, the real origin of these cells is still not clear. Further 
studies and immunohistochemical investigations are needed to differentiate between the 
cells and clarify whether fragments of nerve fibers and retinal neurons could also be torn off 
by ILM removal.  
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